These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 7238849)

  • 1. Cardiovascular effects of flutonidin after acute oral administration.
    Mazzola C; Guffanti E; Ferrario N
    Farmaco Prat; 1981 May; 36(5):262-70. PubMed ID: 7238849
    [No Abstract]   [Full Text] [Related]  

  • 2. [New antihypertensive agent of the imidazoline series: 5-fluoro-methyl-imidazolidinylidene-benzamine-monohydrochloride (flutonidin)].
    Brunner H; Djawan S; Dorda W; Penner E; Grabner G
    Arzneimittelforschung; 1977; 27(8):1599-604. PubMed ID: 334188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypotensive action and side-effects of flutonidin in normal subjects. A double-blind controlled trial.
    Sala P; Chierichetti SM; Ferrari P
    Eur J Clin Pharmacol; 1979; 16(6):375-9. PubMed ID: 393519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between the effects of ST 600 and catapres.
    Kho TL; Schalekamp MA; Zaal GA; Wester A; Birkenhäger WH
    Arch Int Pharmacodyn Ther; 1975 Apr; 214(2):347-50. PubMed ID: 1156039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between the effects of ST 600 and clonidine.
    Kho TL; Schalekamp MA; Zaal GA; Wester A; Birkenhäger WH
    Arch Int Pharmacodyn Ther; 1975 Sep; 217(1):162-9. PubMed ID: 1190909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central cardiovascular effects of flutonidine in adult fowls.
    Marmo E; Di Mezza F; Nistico G; Somma A; Ariello B; Imperatore A
    Agressologie; 1981; 22(6):269-72. PubMed ID: 7325301
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparative trial of timolol and flutonidin as antihypertensive agents.
    Salvadeo A; Segagni S; Villa G; Galli F; Piazza W; Bovio G
    Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):78-84. PubMed ID: 7037661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redistribution of cardiac output to the kidneys during oral nadolol administration.
    Textor SC; Fouad FM; Bravo EL; Tarazi RC; Vidt DG; Gifford RW
    N Engl J Med; 1982 Sep; 307(10):601-5. PubMed ID: 7110207
    [No Abstract]   [Full Text] [Related]  

  • 9. [A new antihypertensive drug: clonidine or Catapressan].
    Amery A; Bossaert H; Deruyttere M; Verstreken G
    Acta Clin Belg; 1969; 24(6):334-55. PubMed ID: 4923381
    [No Abstract]   [Full Text] [Related]  

  • 10. [The acute effect of ST-155 hypotensive agent, on cardiac and renal hemodynamics].
    Vorburger C; Bütikofer E; Weiss S; Diacon C
    Helv Med Acta; 1967; 34(1):Suppl:133-4. PubMed ID: 5589186
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacological properties of 2-(2-chloro-p-toluidino)-2-imidazoline-nitrate (tolonidine), a new antihypertensive agent. II. Action on cardiac contraction, circulatory parameters, autonomic receptors and diuresis.
    Cosnier D; Labrid C; Rispat G; Streichenberger G
    Arzneimittelforschung; 1975 Nov; 25(11):1802-6. PubMed ID: 1243090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Single dose studies on the effect of 2-(2,6-dichlorphenylamino)-2-imidazoline-hydrochloride on blood pressure and pulse in hypertonic subjects and on its tolerance].
    Knobloch H; Moor H
    Arzneimittelforschung; 1966 Sep; 16(9):1169-74. PubMed ID: 6014737
    [No Abstract]   [Full Text] [Related]  

  • 13. [Combination of a new synthetic anti-hypertensive drug and a diuretic. Clinical results].
    Medeiros RF
    Rev Bras Med; 1972 May; 29(5):255-7. PubMed ID: 5053075
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmacoclinical study of oral butofilolol in arterial hypertension. Effects on heart rate, blood pressure and the renin-angiotensin system].
    Martinand A; Corvol P; Milliez P
    Therapie; 1983; 38(3):265-9. PubMed ID: 6137087
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cerebral hemodynamics under the effect of 2-(2,6-dichlorphenylamino)-2-imidazoline hydrochloride].
    Deisenhammer E; Klausberger EM
    Arzneimittelforschung; 1966 Sep; 16(9):1161-2. PubMed ID: 6014734
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of olmesartan medoxomil in the rat monocrotaline model of pulmonary hypertension.
    Kato T; Nasu T; Sonoda H; Ito KM; Ikeda M; Ito K
    J Cardiovasc Pharmacol; 2008 Jan; 51(1):18-23. PubMed ID: 18209564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A new antihypertensive imidazoline derivative (St 600, Fluoronidine): I. Haemodynamic investigations at rest and during exercise (author's transl)].
    Djawan S; Mlezoch J; Niederberger M; Penner E; Grabner G
    Wien Klin Wochenschr; 1976 Mar; 88(6):199-206. PubMed ID: 973381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of chronic administration of moxonidine in hypertensive rats SHR-SP].
    Khokhlova ON; Murashev AN; Lavrova LN; Medvedev OS
    Eksp Klin Farmakol; 2000; 63(5):21-3. PubMed ID: 11109519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and experimental study with the new blood pressure depressant 2-(2,6-dichlorphenylamino)-2-imidazole-hydrochloride].
    Grabner G; Michalek P; Pokorny D; Vormittag E
    Arzneimittelforschung; 1966 Sep; 16(9):1174-9. PubMed ID: 6014738
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthesis and antihypertensive activity of imidazo[2,1-b]-thiazoles bearing a 2,6-dichlorophenyl group.
    Andreani A; Rambaldi M; Locatelli A; Cristoni A; Malandrino S; Pifferi G
    Acta Pharm Nord; 1992; 4(2):93-6. PubMed ID: 1388775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.